HuGE Literature Finder
Records
1
-
30
| Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane. The journal of gene medicine 2022 Jun e3434. Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi |
| Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surgical oncology 2020 Sep 35 388-398. Puerta-García E, Urbano-Pérez D, Carrasco-Campos M I, Pérez-Ramírez C, Segura-Pérez A, Calleja-Hernández , Cañadas-Garre |
| Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population. Medical science monitor : international medical journal of experimental and clinical research 2019 Apr 25 2959-2965. Zhang Shudong, Wang Binshuai, Zhang Fan, Ye Jianfei, Ge Liyuan, Ma Lul |
| Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus. IUBMB life 2019 Mar . Rastgar-Moghadam Azam, Mehramiz Mehrane, Shahidsales Soodabeh, Entezari Malihe, Hassanian Seyed Mahdi, Talebian Sahar, Nourbakhsh Mahnaz, Ferns Gordon A, Avan Am |
| Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. Oncotarget 2018 Mar 9 (18): 14109-14123. Zhang Yuanyuan, Mai Haixing, Guo Gang, Bi Guofang, Hao Guangtao, Li Yuanyuan, Wang Xiaofang, Cheng Longmei, Wang Jing, Dong Ruihua, Liu Zeyuan, Chen Lijun, Qu Hengy |
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
| ABCB1 3435TT and ABCG2 421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients. Oncotarget 2017 Dec 8 (67): 111041-111052. Li Wanjun, Zhang Dan, Du Fen, Xing Xuemei, Wu Ying, Xiao Dong, Liang Ming, Fan Zhigang, Zhao Peng, Liu Tao, Li Guoy |
| Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World journal of gastroenterology 2017 Sep 23 (36): 6674-6684. De Mattia Elena, Cecchin Erika, Polesel Jerry, Bignucolo Alessia, Roncato Rossana, Lupo Francesco, Crovatto Marina, Buonadonna Angela, Tiribelli Claudio, Toffoli Giusep |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. Cancer chemotherapy and pharmacology 2017 Mar . Tandia Mahamadou, Mhiri Asma, Paule Bernard, Saffroy Raphaël, Cailliez Valérie, Noé Gaëlle, Farinotti Robert, Bonhomme-Faivre Lauren |
| Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients. Biological & pharmaceutical bulletin 2017 40 (4): 458-464. Watanabe Aimi, Yamamoto Kazuhiro, Ioroi Takeshi, Hirata Sachi, Harada Kenichi, Miyake Hideaki, Fujisawa Masato, Nakagawa Tsutomu, Yano Ikuko, Hirai Mido |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| Association of Single-Nucleotide Polymorhism C3435T in the ABCB1 Gene with Opioid Sensitivity in Treatment of Postoperative Pain. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2016 Nov 37 (2-3): 73-80. Dzambazovska-Trajkovska Vanja, Nojkov Jordan, Kartalov Andrijan, Kuzmanovska Biljana, Spiroska Tatjana, Seljmani Redzep, Trajkovski Gjorgji, Matevska-Geshkovska Nadica, Dimovski Aleksand |
| Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma. Cancer chemotherapy and pharmacology 2016 Sep . Kato Hiroshi, Sassa Naoto, Miyazaki Masayuki, Takeuchi Mio, Asai Miho, Iwai Akane, Noda Yukihiro, Gotoh Momokazu, Yamada Kiyofu |
| BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen. Cancer chemotherapy and pharmacology 2016 Aug . Chae Jung-Woo, Teo Yi Ling, Ho Han Kiat, Lee Jaeyeon, Back Hyun-Moon, Yun Hwi-Yeol, Karlsson Mats O, Kwon Kwang-Il, Chan Alexand |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer. Cancer chemotherapy and pharmacology 2016 May . de Wit D, Schneider T C, Moes D J A R, Roozen C F M, den Hartigh J, Gelderblom H, Guchelaar H J, van der Hoeven J J, Links T P, Kapiteijn E, van Erp N |
| SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma. Pharmacogenomics 2016 Mar . Duran Ignacio, Hagen Carlos, Arranz José Ángel, Apellaniz-Ruiz María, Pérez-Valderrama Begoña, Sala Nuria, Lainez Nuria, García-Del Muro Xavier, Noguerón Esther, Climent Miguel Ángel, Maroto Pablo, Font Albert, García-Donas Jesús, Gallardo Enrique, López-Criado Pilar, González Del Alba Aránzazu, Sáez María Isabel, Vázquez Sergio, Luque Raquel, Rodríguez-Antona Cristi |
| The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma. Scientific reports 2016 6 20089. Qin Chao, Cao Qiang, Li Pu, Wang Shangqian, Wang Jian, Wang Meilin, Chu Haiyan, Zhou Liqun, Li Xuesong, Ye Dingwei, Zhang Hailiang, Huang Yiran, Dong Baijun, Sun Xiaofeng, Zou Qing, Cai Hongzhou, Sun Lijiang, Zhu Jian, Liu Fade, Ji Junbiao, Cui Li, Wang Xiaoxiang, Zhou Hai, Zhao Hu, Wu Bin, Chen Jianchun, Jiang Minjun, Zhang Zhengdong, Shao Pengfei, Ju Xiaobing, Yin Changj |
| CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma. European urology 2015 Oct 68 (4): 621-9. Diekstra Meta H M, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
| SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma. Oncotarget 2015 Jun 6 (18): 16449-60. Lee Yeon-Su, Kim Bo Hyun, Kim Byung Chul, Shin Aesun, Kim Jin Sook, Hong Seung-Hyun, Hwang Jung-Ah, Lee Jung Ahn, Nam Seungyoon, Lee Sung Hoon, Bhak Jong, Park Joong-W |
| Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients. The pharmacogenomics journal 2015 Mar . Teo Y L, Wee H L, Chue X P, Chau N M, Tan M-H, Kanesvaran R, Wee H L, Ho H K, Chan |
| ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy. Cancer science 2015 Jan 106 (1): 86-93. Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Ham Hye Seon, Lee Kyung Hun, Kim Tae Yong, Kim Yu Jung, Oh Do-Youn, Kim Jee Hyun, Han Wonshik, Jang In-Jin, Kim Tae-You, Park In Ae, Noh Dong You |
| Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data. Pharmacogenetics and genomics 2015 Jan 25 (1): 1-7. Kim In-Wha, Han Nayoung, Kim Myeong Gyu, Kim Therasa, Oh Jung |
| Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma. PloS one 2015 10 (8): e0134102. Chu Ying-Hsia, Li Huihua, Tan Hui Shan, Koh Valerie, Lai Johnathan, Phyo Wai Min, Choudhury Yukti, Kanesvaran Ravindran, Chau Noan Minh, Toh Chee Keong, Ng Quan Sing, Tan Puay Hoon, Chowbay Balram, Tan Min-H |
| Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
| Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms. Journal of biomedical science 2014 21 89. Martinelli Marcella, Scapoli Luca, Cura Francesca, Rodia Maria Teresa, Ugolini Giampaolo, Montroni Isacco, Solmi Rossel |
| Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
| Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (5): 1217-1226. Argalacsova Sona, Slanar Ondrej, Bakhouche Hana, Pertuzelka Lub |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: